Coherent Market Insights Pvt Ltd

Deep Brain Stimulation Devices Market to Surpass US$ 664.4 Million by 2024

Press Release   •   Jan 26, 2017 07:19 EST

Deep Brain Stimulation Devices

Deep brain stimulation (DBS) device, often described as brain pacemaker, aids in alleviating symptoms of Parkinson’s disease (PD). The device is implanted at one of the three FDA approved brain sites to block the electrical signals from these sites to the brain. The three FDA approved targeted brain sites are ventrointermedialis (VIM) nucleus of the thalamus, subthalamic nucleus (STN), and globus pallidus pars interna (GPi). DBS surgery is performed on patient’s suffering from Parkinson’s disease for at least four years, and are on medications albeit with motor complications. Though there are other surgical options such as thalamotomy and pallidotomy, deep brain stimulation is the most preferred option, as it does not involve tissue destruction and is a reversible surgical treatment.

Ask for FREE Request Customization @ https://www.coherentmarketinsights.com/insight/request-customization/84

The global deep brain stimulation devices market was valued at US$ 664.4 million in 2015 and is expected to expand at a CAGR of 8.2% during the forecast period (2016 – 2024).

Increasing incidence of Parkinson’s disease

According to the Parkinson’s Disease Foundation, there are over 10 million people suffering from Parkinson’s disease worldwide as of 2016. As per findings published by the organization, incidence rate increases with age, and only 4% of people with PD are diagnosed before the age of 50 years. In U.S. alone, incidence is as high as 60,000 each year as noted by the Parkinson’s Disease Foundation. According to Parkinson’s Australia Inc., there were approximately 11,544 new cases of PD diagnosed in Australia in 2014, while as per stats released by Parkinson Canada, the number of people suffering from Parkinson’s disease in the country is projected to increase to over 163,700 by 2031 (double than the prevalence in 2011). Increasing incidence of PD across the globe is projected to drive demand for DBS devices.

Development in technology to increase therapeutic outcome and enhance application of DBS in other disease treatment

According to a study published in the Neuron journal in December 2016, deep brain stimulation, targeting entorhinal cortex and hippocampus regions in the brain, demonstrated negative impact on improving memory. Researchers, however, are optimistic about obtaining successful results through further research in enhancing memory, especially in Alzheimer patients.

Activa PC+S system by Medtronic. Inc, is a closed-loop DBS device being utilized for research purpose among few physicians in Europe. This system records the electrical activity in brain and develops an algorithm of the closed-loop system. The device is being tested in patients with advanced Parkinson’s disease. Once commercialized, the closed-loop DBS system would make treatment for Parkinson’s disease more effective and customized according to unique patient needs.

Get for FREE SAMPLE REPORT @ https://www.coherentmarketinsights.com/insight/request-sample/84

Increasing demand for minimally-invasive treatment options in emerging economies

Parkinson’s and Alzheimer disease involves long-term administration of medications, making it unaffordable to major section of the population in emerging economies in Asia, Africa, and Latin America. Advent of minimally-invasive technology has led to increase in demand for such procedures and devices for treatment of chronic disease conditions such as diabetes, stroke, Parkinson’s disease, blood clot, and Alzheimer’s disease. DBS being an effective minimally-invasive therapy for Parkinson’s patients, is projected to gain significant growth traction in emerging economies such as India, China, Brazil, Israel, and North African countries.

ABOUT US

COMPANY OVERVIEW

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. Our global team of over 100 research analysts and freelance consultants provide market intelligence from the very molecular country level and also provide a global perspective of the market. Our team is of the most vital cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive defusion training module.This allows for an objective and unbiased assessment of the market. We pride ourselves in my constantly striving to update our extremely in-depth understanding of the market by closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth path in the future.

CONTACT US

Raj Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel : +1-206-701-6702

Mail tosales@coherentmarketinsights.com

The global deep brain stimulation devices market was valued at US$ 664.4 million in 2015 and is expected to expand at a CAGR of 8.2% during the forecast period - 2024